Form D · Biotechnology
Phenomix CORP
San Diego, CA · CIK 0001424342
Offering snapshot reported Mar 10, 2010 · SEC filing
- Reported sold
- $5.96M Offering amount: $14.9M
- Investors reported
- 31 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 28, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 10, 2010 | Initial | $5,955,935 | No comparison | 31 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-139427
Source: Form D, filed Mar 10, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Baker | Executive |
| Angela Birchler | Executive |
| John Diekman | Director |
| Anton Giorgio Failla | Director |
| Hans Peter Guler | Executive |
| James Harper | Director |
| William Harris | Director |
| Daniel Janney | Director |
| Marie O'farrell | Executive |
| Deepika Pakianathan | Director |
| Laura Shawver | Director, Executive |
| Damion E. Wicker | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5930 Cornerstone Court West, Suite 230
San Diego, CA, 92121
San Diego, CA, 92121